Jennifer F Waljee1, David C Cron, Rena M Steiger, Lin Zhong, Michael J Englesbe, Chad M Brummett. 1. *Section of Plastic Surgery, Department of Surgery, University of Michigan Health System, Ann Arbor, MI †University of Michigan Medical School, Ann Arbor, MI ‡Section of Transplant Surgery, Department of Surgery, University of Michigan Health System, Ann Arbor, MI §Department of Anesthesia, University of Michigan Health System, Ann Arbor, MI.
Abstract
OBJECTIVE: To examine the extent to which preoperative opioid use is correlated with healthcare utilization and costs following elective surgical procedures. SUMMARY BACKGROUND DATA: Morbidity and mortality associated with prescription opioid use is escalating in the United States. The extent to which chronic opioid use influences postoperative outcomes following elective surgery is not well understood. METHODS: Truven Health Marketscan Databases were used to identify adult patients who underwent elective abdominal surgery between June 2009 and December 2012 (n = 200,005). Generalized linear regression was used to determine the effect of preoperative opioid use on postoperative healthcare utilization (length of stay, 30-d readmission, and discharge destination) and cost (hospital stay, 90-, 180-, and 365-d) after adjusting for number of comorbidities, psychological conditions, and demographic characteristics. RESULTS: In this cohort, 8.8% of patients used opioids preoperatively. Compared with non-users, patients using opioids preoperatively were more likely to have a longer hospital stay (2.9 d vs. 2.5 d, P <0.001) and were more likely to be discharged to a rehabilitation facility (3.6% vs. 2.5%, P <0.001), adjusting for covariates. Preoperative opioid use was also correlated with a greater rate of 30-day readmission (4.5% vs. 3.6%, P <0.001) and overall greater expenditures at 90- ($12036.60 vs. $3863.40, P <0.001), 180- ($16973.70 vs. $6790.60, P <0.001), and 365- ($25495.70 vs. $12113.80, P <0.001) days following surgery, adjusted for covariates. Additionally, dose-effects were observed regarding readmission, discharge destination, and late healthcare expenditures. CONCLUSIONS: Preoperative interventions focused on opioid cessation and alternative analgesics may improve the safety and efficiency of elective surgery among chronic opioid users.
OBJECTIVE: To examine the extent to which preoperative opioid use is correlated with healthcare utilization and costs following elective surgical procedures. SUMMARY BACKGROUND DATA: Morbidity and mortality associated with prescription opioid use is escalating in the United States. The extent to which chronic opioid use influences postoperative outcomes following elective surgery is not well understood. METHODS: Truven Health Marketscan Databases were used to identify adult patients who underwent elective abdominal surgery between June 2009 and December 2012 (n = 200,005). Generalized linear regression was used to determine the effect of preoperative opioid use on postoperative healthcare utilization (length of stay, 30-d readmission, and discharge destination) and cost (hospital stay, 90-, 180-, and 365-d) after adjusting for number of comorbidities, psychological conditions, and demographic characteristics. RESULTS: In this cohort, 8.8% of patients used opioids preoperatively. Compared with non-users, patients using opioids preoperatively were more likely to have a longer hospital stay (2.9 d vs. 2.5 d, P <0.001) and were more likely to be discharged to a rehabilitation facility (3.6% vs. 2.5%, P <0.001), adjusting for covariates. Preoperative opioid use was also correlated with a greater rate of 30-day readmission (4.5% vs. 3.6%, P <0.001) and overall greater expenditures at 90- ($12036.60 vs. $3863.40, P <0.001), 180- ($16973.70 vs. $6790.60, P <0.001), and 365- ($25495.70 vs. $12113.80, P <0.001) days following surgery, adjusted for covariates. Additionally, dose-effects were observed regarding readmission, discharge destination, and late healthcare expenditures. CONCLUSIONS: Preoperative interventions focused on opioid cessation and alternative analgesics may improve the safety and efficiency of elective surgery among chronic opioid users.
Authors: David B Reuben; Anika A H Alvanzo; Takamaru Ashikaga; G Anne Bogat; Christopher M Callahan; Victoria Ruffing; David C Steffens Journal: Ann Intern Med Date: 2015-02-17 Impact factor: 25.391
Authors: Jarred W Younger; Larry F Chu; Nicole T D'Arcy; Kiley E Trott; Laura E Jastrzab; Sean C Mackey Journal: Pain Date: 2011-04-30 Impact factor: 6.961
Authors: Pooja Lagisetty; Amy Bohnert; Jenna Goesling; Hsou Mei Hu; Breanna Travis; Kiran Lagisetty; Chad M Brummett; Michael J Englesbe; Jennifer Waljee Journal: Ann Surg Date: 2019-03-01 Impact factor: 12.969
Authors: John Pang; Kathryn R Tringale; Viridiana J Tapia; William J Moss; Megan E May; Timothy Furnish; Linda Barnachea; Kevin T Brumund; Assuntina G Sacco; Robert A Weisman; Quyen T Nguyen; Jeffrey P Harris; Charles S Coffey; Joseph A Califano Journal: JAMA Otolaryngol Head Neck Surg Date: 2017-12-01 Impact factor: 6.223
Authors: Margaret E Smith; Jay S Lee; Aaron Bonham; Oliver A Varban; Jonathan F Finks; Arthur M Carlin; Amir A Ghaferi Journal: Surg Endosc Date: 2018-10-23 Impact factor: 4.584
Authors: Joe Habbouche; Jay Lee; Rena Steiger; James M Dupree; Caitlin Khalsa; Michael Englesbe; Chad Brummett; Jennifer Waljee Journal: JAMA Surg Date: 2018-12-01 Impact factor: 14.766
Authors: Pooja Lagisetty; Amy Bohnert; Jenna Goesling; Hsou Mei Hu; Breanna Travis; Kiran Lagisetty; Chad M Brummett; Michael J Englesbe; Jennifer Waljee Journal: Ann Surg Date: 2020-08 Impact factor: 12.969
Authors: Taryn E Hassinger; Elizabeth D Krebs; Florence E Turrentine; Robert H Thiele; Bethany M Sarosiek; Sook C Hoang; Charles M Friel; Traci L Hedrick Journal: Surg Endosc Date: 2020-05-11 Impact factor: 4.584